Herb Formula ZhenRongDan Balances Sex Hormones, Modulates Organ Atrophy, and Restores ERα and ERβ Expressions in Ovariectomized Rats

Abstract EN

Herb mixtures are widely used for treatment of the menopausal syndrome long before the hormonal therapy.

However, there is insufficient data for herb remedies in treating menopausal syndromes.

Here we aim to investigate the effect of ZhenRongDan (ZRD) in balancing female hormones, regulating expression of estrogen receptors (ERs), and preventing organ atrophy in menopausal rats.

Rats that underwent bilateral ovariectomy were used in the experiments; the effects of ZRD on serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), and estradiol (E2) levels were observed.

Histology of vagina and ERs expression in vagina, uterus, and adrenal gland were also examined.

ELISAs were used to analyze the changes of FSH, LH, PRL, and E2 in serum, and the morphological changes of the cervical epithelium cells were observed by Hematoxylin & Eosin (H&E) staining.

Immunohistochemistry and western blot were applied to detect estrogen receptors subtypes alpha (ERα) and beta (ERβ) expression in vagina, uterus, and adrenal gland.

We found that ZRD could significantly reduce the weight of the adrenal gland and increase the weight of the uterus.

It could decrease the release of FSH and LH as well as increasing E2 and PRL levels.

Furthermore, ZRD could improve the number of cervical vaginal epithelial cells and increase the thickness of the vaginal wall.

And the altered expressions of ERα and ERβ are also restored by ZRD.

ZRD could obviously relieve the endocrine disorders, modulate organ atrophy, and restore ERα and ERβ expression in the ovariectomized rat model.